Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

ACCELERATE DIAGNOSTICS, INC.

(AXDX)
  Report
Delayed Nasdaq  -  04:00 2022-12-07 pm EST
0.8200 USD   +7.89%
11/17Certain Warrants of Accelerate Diagnostics, Inc. are subject to a Lock-Up Agreement Ending on 17-NOV-2022.
CI
11/17Certain Stock Options of Accelerate Diagnostics, Inc. are subject to a Lock-Up Agreement Ending on 17-NOV-2022.
CI
11/17Certain Common Stock of Accelerate Diagnostics, Inc. are subject to a Lock-Up Agreement Ending on 17-NOV-2022.
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Sector Update: Health Care

08/18/2022 | 03:50pm EST


ę MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
ACCELERATE DIAGNOSTICS, INC. 7.89% 0.82 Delayed Quote.-84.29%
NASDAQ COMPOSITE -0.51% 10958.55 Real-time Quote.-29.59%
All news about ACCELERATE DIAGNOSTICS, INC.
11/17Certain Warrants of Accelerate Diagnostics, Inc. are subject to a Lock-Up Agreement End..
CI
11/17Certain Stock Options of Accelerate Diagnostics, Inc. are subject to a Lock-Up Agreemen..
CI
11/17Certain Common Stock of Accelerate Diagnostics, Inc. are subject to a Lock-Up Agreement..
CI
11/14Accelerate Diagnostics : Q3 Earnings Snapshot
AQ
11/14ACCELERATE DIAGNOSTICS, INC Management's Discussion and Analysis of Financial Conditio..
AQ
11/14Accelerate Diagnostics, Inc. Reports Earnings Results for the Third Quarter and Nine Mo..
CI
11/14Accelerate Diagnostics, Inc. Provides Earnings Guidance for the Year 2022
CI
11/14Transcript : Accelerate Diagnostics, Inc., Q3 2022 Earnings Call, Nov 14, 202..
CI
11/14Earnings Flash (AXDX) ACCELERATE DIAGNOSTICS Posts Q3 Revenue $3M
MT
11/14Accelerate Diagnostics Reports Third Quarter 2022 Financial Results
PR
More news
Analyst Recommendations on ACCELERATE DIAGNOSTICS, INC.
More recommendations
Financials (USD)
Sales 2022 12,7 M - -
Net income 2022 -60,3 M - -
Net Debt 2022 - - -
P/E ratio 2022 -1,08x
Yield 2022 -
Capitalization 81,3 M 81,3 M -
Capi. / Sales 2022 6,42x
Capi. / Sales 2023 4,75x
Nbr of Employees 220
Free-Float 73,2%
Chart ACCELERATE DIAGNOSTICS, INC.
Duration : Period :
Accelerate Diagnostics, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ACCELERATE DIAGNOSTICS, INC.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 2
Last Close Price 0,82 $
Average target price 2,00 $
Spread / Average Target 144%
EPS Revisions
Managers and Directors
Jack Phillips President, Chief Executive Officer & Director
Steven Reichling Chief Financial & Accounting Officer
John Patience Chairman
Lawrence Mertz Chief Technology Officer
Jack W. Schuler Independent Director
Sector and Competitors
1st jan.Capi. (M$)
ACCELERATE DIAGNOSTICS, INC.-84.29%81
THERMO FISHER SCIENTIFIC-16.35%219 934
DANAHER CORPORATION-18.47%195 269
INTUITIVE SURGICAL, INC.-25.42%94 693
BOSTON SCIENTIFIC CORPORATION6.31%65 356
SIEMENS HEALTHINEERS AG-25.07%57 925